Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 19 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 657099 |
| 30 | 3 | INFECTIOUS DISEASES//MICROBIOLOGY//JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 113720 |
| 130 | 2 | ACINETOBACTER BAUMANNII//CARBAPENEMASE//EXTENDED SPECTRUM BETA LACTAMASE | 23604 |
| 18873 | 1 | AVIBACTAM//CEFTAZIDIME AVIBACTAM//CEFTOLOZANE TAZOBACTAM | 555 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | AVIBACTAM | authKW | 1399250 | 6% | 79% | 31 |
| 2 | CEFTAZIDIME AVIBACTAM | authKW | 1326570 | 5% | 81% | 29 |
| 3 | CEFTOLOZANE TAZOBACTAM | authKW | 1035843 | 4% | 79% | 23 |
| 4 | DELAFLOXACIN | authKW | 695624 | 3% | 88% | 14 |
| 5 | CEFTOLOZANE | authKW | 511067 | 2% | 75% | 12 |
| 6 | SOLITHROMYCIN | authKW | 404174 | 2% | 65% | 11 |
| 7 | ZABOFLOXACIN | authKW | 309164 | 1% | 78% | 7 |
| 8 | CEM 101 | authKW | 227144 | 1% | 100% | 4 |
| 9 | DW 224A | authKW | 227144 | 1% | 100% | 4 |
| 10 | FR264205 | authKW | 227144 | 1% | 100% | 4 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Microbiology | 13915 | 65% | 0% | 362 |
| 2 | Pharmacology & Pharmacy | 9868 | 76% | 0% | 421 |
| 3 | Infectious Diseases | 5061 | 29% | 0% | 159 |
| 4 | Chemistry, Medicinal | 44 | 3% | 0% | 19 |
| 5 | Toxicology | 11 | 2% | 0% | 12 |
| 6 | Immunology | 10 | 4% | 0% | 22 |
| 7 | Medical Ethics | 3 | 0% | 0% | 1 |
| 8 | Biochemical Research Methods | 2 | 2% | 0% | 9 |
| 9 | Ethics | 0 | 0% | 0% | 1 |
| 10 | Medicine, Legal | 0 | 0% | 0% | 1 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | ANTIINFECT DEV | 137050 | 5% | 9% | 26 |
| 2 | XDR PATHOGEN | 92914 | 1% | 27% | 6 |
| 3 | INFECT INNOVAT MED | 60477 | 1% | 15% | 7 |
| 4 | CARNEGIE 210 | 56786 | 0% | 100% | 1 |
| 5 | CLIN PHARMACOL TRIAL UNIT | 56786 | 0% | 100% | 1 |
| 6 | DEP MED PREVENT SALUD PUBL MICROBIOL | 56786 | 0% | 100% | 1 |
| 7 | DIAGNOST BIOMEDMICROBIOL SERV | 56786 | 0% | 100% | 1 |
| 8 | DISCOVERY SCI INNOVAT MED UNIT | 56786 | 0% | 100% | 1 |
| 9 | DMPK ONCOL IMED | 56786 | 0% | 100% | 1 |
| 10 | HANWALT MED RECHT ARZT VERTRAGSARZT CHEFARZT | 56786 | 0% | 100% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 91168 | 35% | 1% | 197 |
| 2 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 18690 | 12% | 1% | 65 |
| 3 | INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 15511 | 6% | 1% | 33 |
| 4 | DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | 3736 | 3% | 0% | 19 |
| 5 | JOURNAL DES ANTI-INFECTIEUX | 3066 | 0% | 3% | 2 |
| 6 | EXPERT REVIEW OF ANTI-INFECTIVE THERAPY | 2682 | 1% | 1% | 7 |
| 7 | REVISTA ESPANOLA DE QUIMIOTERAPIA | 2203 | 1% | 1% | 4 |
| 8 | FUTURE MICROBIOLOGY | 848 | 1% | 0% | 4 |
| 9 | DRUGS OF THE FUTURE | 845 | 1% | 0% | 5 |
| 10 | DRUGS | 790 | 2% | 0% | 9 |
Author Key Words |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | AVIBACTAM | 1399250 | 6% | 79% | 31 | Search AVIBACTAM | Search AVIBACTAM |
| 2 | CEFTAZIDIME AVIBACTAM | 1326570 | 5% | 81% | 29 | Search CEFTAZIDIME+AVIBACTAM | Search CEFTAZIDIME+AVIBACTAM |
| 3 | CEFTOLOZANE TAZOBACTAM | 1035843 | 4% | 79% | 23 | Search CEFTOLOZANE+TAZOBACTAM | Search CEFTOLOZANE+TAZOBACTAM |
| 4 | DELAFLOXACIN | 695624 | 3% | 88% | 14 | Search DELAFLOXACIN | Search DELAFLOXACIN |
| 5 | CEFTOLOZANE | 511067 | 2% | 75% | 12 | Search CEFTOLOZANE | Search CEFTOLOZANE |
| 6 | SOLITHROMYCIN | 404174 | 2% | 65% | 11 | Search SOLITHROMYCIN | Search SOLITHROMYCIN |
| 7 | ZABOFLOXACIN | 309164 | 1% | 78% | 7 | Search ZABOFLOXACIN | Search ZABOFLOXACIN |
| 8 | CEM 101 | 227144 | 1% | 100% | 4 | Search CEM+101 | Search CEM+101 |
| 9 | DW 224A | 227144 | 1% | 100% | 4 | Search DW+224A | Search DW+224A |
| 10 | FR264205 | 227144 | 1% | 100% | 4 | Search FR264205 | Search FR264205 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |